Loading viewer...
conference
Format: PDF conference
Tonix Pharmaceuticals Holding Corp. presents its development pipeline focused on Tonmya (TNX-102 SL), a candidate for fibromyalgia management, at BIO International 2024. The company develops therapeutics for pain, neurologic, psychiatric, and addiction conditions through its central nervous system portfolio. Tonix is pursuing a New Drug Application filing with the FDA for Tonmya's approval.
investor_presentation
75 Pages
conference
13 Pages
Mister Car Wash, Inc.
CapitaLand Integrated Commercial Trust 2021 CEO Conference
conferenceconference
40 Pages
CapitaLand Integrated Commercial Trust